Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Neurocrit Care. 2024 Aug;41(1):244-254. doi: 10.1007/s12028-024-01938-y. Epub 2024 Feb 8.
Aneurysmal subdural hematoma (aSDH) is a rare complication of aneurysm rupture, affecting between 0.5 and 7.9% of patients with aneurysmal subarachnoid hemorrhage (aSAH). The clinical presentation, course, and outcomes of these patients are largely unknown.
This study aims to systematically review the literature to evaluate the demographics, clinical presentation, aneurysm location, treatment options, and outcomes of patients with aSDH with and without aSAH.
In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, we conducted a systematic review of three databases (PubMed, EMBASE, and Google Scholar). From identified reports, we extracted data on patients' demographics, clinical presentation, imaging findings, surgical interventions, and clinical outcomes. We compared clinical outcomes, need for surgical treatment, and aneurysm location between patients with aSDH with and without concurrent aSAH using χ and Fisher's exact tests. We used simple and multivariable logistic regression models to further examine the association between the presence of aSAH and surgical treatment with clinical outcomes.
We identified 112 articles with a total of 270 patients (70% women, mean age 52.8 [± 15.5] years). The most common aneurysm locations were the middle cerebral artery, followed by the posterior communicating artery, and the internal carotid artery. Patients with isolated aSDH fully recovered more frequently than those with concomitant aSAH (38% vs. 6%). The presence of aSAH increased the odds of unfavorable outcome (odds ratio [OR] 2.68, 95% confidence interval [CI] 1.34-5.37). Surgical treatment was inversely associated with unfavorable outcome in the univariable (OR 0.48, 95% CI 0.28-0.84) but not in the multivariable analysis (OR 0.76, 95% CI 0.35-1.66).
aSDH occurs infrequently. Simultaneous presence of both aSDH and aSAH from an aneurysmal source is associated with poor outcomes. Surgical treatment is associated with lower rates of unfavorable outcomes including death and severe disability.
脑 膜 下 血 肿(aSDH)是颅内动脉瘤破裂的罕见并发症,影响 0.5%至 7.9%的蛛网膜下腔出血(aSAH)患者。这些患者的临床表现、病程和结局在很大程度上是未知的。
本研究旨在通过系统综述文献,评估有和无并发 aSAH 的 aSDH 患者的人口统计学、临床表现、动脉瘤位置、治疗选择和结局。
根据系统评价和荟萃分析的首选报告项目,我们对三个数据库(PubMed、EMBASE 和 Google Scholar)进行了系统综述。从确定的报告中,我们提取了患者人口统计学、临床表现、影像学发现、手术干预和临床结局的数据。我们使用 χ 和 Fisher 确切检验比较了有和无并发 aSAH 的 aSDH 患者的临床结局、手术治疗需求和动脉瘤位置。我们使用简单和多变量逻辑回归模型进一步研究了 aSAH 的存在与手术治疗与临床结局之间的关联。
我们共确定了 112 篇文章,共涉及 270 名患者(70%为女性,平均年龄 52.8 [±15.5] 岁)。最常见的动脉瘤位置是大脑中动脉,其次是后交通动脉和颈内动脉。完全恢复的孤立性 aSDH 患者比并发 aSAH 的患者更频繁(38% vs. 6%)。并发 aSAH 增加了不良结局的可能性(优势比 [OR] 2.68,95%置信区间 [CI] 1.34-5.37)。手术治疗在单变量分析中与不良结局呈负相关(OR 0.48,95% CI 0.28-0.84),但在多变量分析中无相关性(OR 0.76,95% CI 0.35-1.66)。
aSDH 发生率较低。同时存在动脉瘤源性的 aSDH 和 aSAH 与不良结局相关。手术治疗与不良结局(包括死亡和严重残疾)发生率较低相关。